| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Surgery [P. W. A. M., M. S. L., E. T. K.] and Pathology [H. I.], Tulane University Medical School, New Orleans, Louisiana 70112
Skin tests to various common antigens, dinitrochlorobenzene, and 5-fluorouracil (5-FU) were performed on patients being treated for cutaneous neoplasms with topical 5-FU cream. Eleven of 15 patients tested both before and after therapy converted from skin test negative to positive with respect to 5-FU. This conversion correlated with positive dinitrochlorobenzene skin tests and therapeutic cure. The relation between the induction of delayed hypersensitivity reactions to 5-FU following treatment with topical 5-FU and the cure rate for cutaneous neoplasms showed a trend toward correlation.
1 Supported in part by the Tulane Skin Cancer Research Fund; National Cancer Institute Grants 5-PO2, CA-05837, 5-TO1, CA-05108, and CA-80807; Eustis Fund; and Women's Auxiliary of the VFW.
3 Associate Professor of Surgery.
Received 8/14/74. Accepted 2/ 7/75.
This article has been cited by other articles:
![]() |
D. K. Goette and R. B. Odom Allergic Contact Dermatitis to Topical Fluorouracil Arch Dermatol, August 1, 1977; 113(8): 1058 - 1061. [Abstract] [PDF] |
||||
![]() |
D. K. Goette, R. B. Odom, and R. Owens Allergic Contact Dermatitis From Topical Fluorouracil Arch Dermatol, February 1, 1977; 113(2): 196 - 198. [Abstract] [PDF] |
||||
![]() |
T. Breza, J. R. Taylor, and W. H. Eaglstein Noninflammatory Destruction of Actinic Keratoses by Fluorouracil Arch Dermatol, September 1, 1976; 112(9): 1256 - 1258. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |